U.S. Sen. Gary Peters foresaw the pain points the country’s manufacturers would encounter during the COVID-19 pandemic and he’s actively pushing legislation he thinks could make the industry more resilient. In Peters’ role with the Senate Committee on Homeland Security and Governmental Affairs, the Michigan Democrat and his fellow committee members launched an investigation into high drug prices. This deep dive, which was released in a 2019 report, revealed an overreliance on an offshore supply chain for key medical equipment. Read the full article from mibiz.com.